BioSpace News Archive

CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX: TRST), one of Canada’s leading and most trusted licensed producers of cannabis, is thrilled to announce that it has won seven top 2018 Canadian Cannabis Awards, dominating the annual industry awards

THE outstanding companies and leaders of the North’s life sciences sector – which is worth more than £13bn to the economy- were honoured last night at the 17th annual Bionow Awards.

Co-Diagnostics, Inc. announced today that it will discuss the Company’s recent progress and upcoming sales expectations on Tuesday, December 4, 2018 at 4:00 pm ET (3:00 pm CT) in a Lytham Partners’ Virtual Investors Conference Presentation.

Healthcare Trust of America, Inc. (NYSE:HTA), the largest public owner and operator of medical office buildings in the United States is proud to be an Emerald sponsor of St. Joseph Health/ Mission Hospital’s Holiday Gala and will be in attendance during the December 1, 2018 event at the Monarch Beach Resort in Orange County.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. from June 4, 2018 through September 25, 2018, inclusive (the “Class Period”) of the important December 3, 2018 lead plaintiff deadline in the class action.

MaSTherCell S.A. a subsidiary of Orgenesis Inc. (NASDAQ: ORGS) through Masthercell Global Inc., a cell therapy-dedicated Contract Development and Manufacturing Organization (CDMO) today announces the launch of a new 600m² production wing at its Belgium site.

TerrAscend Corp. is pleased to announce the successful completion of its previously announced capital reorganization involving Canopy Growth Corporation, Canopy Rivers Corporation and entities controlled by Jason Wild, Chairman of the Company (the “Arrangement”), which paves the way for TerrAscend to explore and pursue growth opportunities internationally.

University of Mississippi’s Dr. David Felton recognized by the American College of Prosthodontists

AbbVie announced today patent license agreements with Pfizer over its proposed biosimilar adalimumab product.